Logo image of DRMA

DERMATA THERAPEUTICS INC (DRMA) Stock Analyst Ratings

USA - NASDAQ:DRMA - US2498455045 - Common Stock

5.02 USD
-0.18 (-3.46%)
Last: 9/30/2025, 4:30:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to DRMA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.2. This target is 103.19% above the current price.
DRMA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DRMA.
In the previous month the buy percentage consensus was at a similar level.
DRMA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

DRMA Historical Analyst RatingsDRMA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -47 -43 -39 -35 -31 -27 -23 -19 -15 -11 -7 -3 2 4 6

Price Target & Forecast

Price Low Median Mean High 5.0210.1010.2010.2010.50 - 101.20% 103.19% 103.19% 109.16%

Related screens

DRMA Current Analyst RatingDRMA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-08-21 Maxim Group Maintains Buy -> Buy
2025-05-21 Maxim Group Maintains Buy -> Buy
2024-08-21 Maxim Group Maintains Buy -> Buy
2023-03-23 Maxim Group Maintains Buy
2021-09-21 Brookline Capital Initiate Buy
2021-09-14 Maxim Group Initiate Buy